Arrowhead Pharmaceuticals, Inc. (ARWR)

47.78 +0.63 (+1.34%) USD  |  NASDAQ  |  Nov 13, 16:00
47.56 -0.22 (-0.46%) After-Hours: 19:59
More

Arrowhead Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual Revenue Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
September 30, 2029 --
September 30, 2028 --
September 30, 2027 --
Date Value
September 30, 2026 --
September 30, 2025 --
September 30, 2024 --

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Nektar Therapeutics Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
TG Therapeutics, Inc. Upgrade